UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
April 25, 2018
|
||||
|
Date of Report (Date of earliest event reported)
|
||||
|
NU SKIN ENTERPRISES, INC.
|
||||
|
(Exact name of registrant as specified in its charter)
|
||||
|
Delaware
|
001-12421
|
87-0565309
|
||
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification Number)
|
||
|
75 West Center Street
Provo, Utah 84601
|
||||
|
(Address of principal executive offices and zip code)
|
||||
|
(801) 345-1000
|
||||
|
(Registrant's telephone number, including area code)
|
||||
|
N/A
|
||||
|
(Former name or former address, if changed since last report)
|
||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
□ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
□ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
| □ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
| □ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company □
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □
| Item 7.01 |
Regulation FD Disclosure.
|
An electronic copy of the Letter to Shareholders, excerpted from the Nu Skin Enterprises, Inc. 2017 Annual Report to Shareholders, is attached hereto as Exhibit 99.1. The 2017 Annual Report to Shareholders will be first sent or given to our shareholders on or about April 26, 2018. A complete copy of the 2017 Annual Report to Shareholders can be obtained on the Investor Relations portion of our website, ir.nuskin.com, or by contacting our Investor Relations Department, telephone: 801-345-1000, e-mail: investorrelations@nuskin.com, address: 75 West Center Street, Provo, Utah 84601.
The information furnished pursuant to this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibit.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NU SKIN ENTERPRISES, INC.
(Registrant)
(Registrant)
/s/ Mark H. Lawrence
Mark H. Lawrence
Chief Financial Officer
Chief Financial Officer
Date: April 25, 2018
DEAR SHAREHOLDER,
The past year has been one of growth and renewal for Nu Skin. In addition to welcoming a new management team, we introduced several new products and began to execute our renewed vision for growth.
Our vision is simple—to become the world's leading opportunity platform by empowering our people to improve lives. In 2017, we made great strides toward making this vision a reality through our growth strategy highlighted by:
|
•
|
Three percent year-over-year revenue growth ($2.28 billion)
|
|
•
|
$130 million of revenue from Q4 introduction of our new ageLOC® LumiSpa® device
|
|
•
|
Eight percent year-over-year customer growth
|
|
•
|
Double-digit growth in sales leaders
|
|
•
|
Generated over $300 million in cash flow from operations
|
|
•
|
Introduced several new products, including ageLOC® LumiSpa®, Dr. Dana Nail Renewal System, Powerlips Fluid, and RAU
|
|
•
|
Making good progress in leveraging social selling to empower sales leaders and grow the business
|
GROW
In 2017, we laid the groundwork for our strategy to grow the business. This strategy is centered on customer acquisition and is best summed up in four key areas—engaging Platforms, enabling Products, empowering Programs, and future Potential. While we are still in the preliminary stages of executing initiatives in each of these areas, our strategy created momentum that we expect will be a catalyst for continued growth in 2018 and beyond.
PLATFORMS
On the Platforms front, we have continued to make progress in our use of online social platforms to help our sales leaders acquire new customers. Our growth strategy is centered on customer acquisition, and we view social selling and providing a positive customer experience as key drivers for our business.
We are seeing strong use of social selling in many of our markets, with double-digit customer gains in the regions of Americas and South Asia/Pacific. In 2018, we will continue to focus on developing platform tools, technologies, and training to enhance our sales leaders' ability to build a socially enabled business.
PRODUCTS
Throughout our history, we have established a legacy of product innovation by delivering world-class products that provide incomparable benefits. At our Nu Skin LIVE! global sales event, we unveiled ageLOC® LumiSpa®, our latest skin care device. The fourth quarter introduction of this unique product accounted for approximately $130 million in sales, generating strong momentum in all of our markets. At LIVE!, we also previewed several additional products that have been developed to support sales leaders' social selling efforts. In 2018, we will launch some of these products in our markets, providing us with great ammunition to continue our momentum throughout the year.
PROGRAMS
Regarding our Programs, we are dedicated to delivering the world's leading opportunity through new and enhanced programs to better empower our sales force. The primary program we will be focused on in 2018 is called Velocity. Velocity is an enhanced sales compensation program intended to reward sales leaders for improved performance in a faster and more flexible manner—both vital for today's entrepreneurs. Early reaction from our sales force to this program strengthens our belief that Velocity will be a meaningful contributor to sales leader growth in the future, and we plan to execute the global rollout of Velocity over the next 24 months—except in Mainland China, which operates under a different business model.
POTENTIAL
We are also making significant investments to advance our long-term growth prospects and return greater value to our shareholders. For example, we recently completed the acquisition of two manufacturing partners in which we previously held non-controlling equity ownership, as well as a packaging company. Their collective solutions and facilities enhance our business by enabling us to bring product innovations to our customers more rapidly and effectively. We anticipate these acquisitions will be accretive to our annual results and will be meaningful contributors to our future success.
In summary, our future is bright! We have a solid foundation of more than 30 years to build on and are aggressively pursuing our 4P growth strategy. We drove renewed growth in 2017 and expect to accelerate that growth in 2018 and into the future, creating value and opportunity for our customers, sales leaders, and shareholders.
As always, thank you for your ongoing support.
Sincerely,
/s/ Ritch Wood
RITCH WOOD
Chief Executive Officer